<?xml version="1.0" encoding="UTF-8"?>
<p id="Par8">The ongoing need to combat existing and emerging viral infections calls for continued collaboration between medicinal chemists and biomedical researchers to identify and develop new therapies, harnessing both 'serendipitous' screening strategies and rational design, as exemplified in the discovery of acyclovir and the HIV protease inhibitors. And finally, from a global health perspective, continued efforts to make these therapies available to all those that need them are highly warranted.</p>
